Availability of Preparatory Documents for the Combined General Meeting (Ordinary and Extraordinary Sessions) of May 23, 2018

information fournie par Boursorama •02/05/2018 à 18:00

Availability of Preparatory Documents for the Combined General Meeting (Ordinary and Extraordinary Sessions) of May 23, 2018

Strasbourg, France, May 2, 2018, 06:00 p.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies announced that the Combined General Meeting of Transgene’s shareholders will be held on May 23, 2018, at 10 am at the Company’s registered office (400, boulevard Gonthier d’Andernach, 67400 Illkirch-Graffenstaden, France).

The notice of meeting, comprising the agenda and the draft resolutions was published in the Bulletin des Annonces Légales Obligatoires (BALO) n° 39 of March 30, 2018.

These notices include information on how to attend and vote at the General Meeting.

Information and documents pertaining to the Combined General Meeting are available in the Investors / General Shareholders Meeting section of Transgene’s website www.transgene.fr/AG2018.